About Us Careers Contact Us

Inquiry List

* Name:
* Phone:
* Service & Products of Interested: [Isotope Labeled Inhibitors] Cefiderocol-[d6]
Project Description:
* Quantity
* Email:
* Organization We recommend you to leave us your work email address so that we can serve you better. Please leave your organization information here if you don't have a work email address.
* Verification Code:

Our Highlights

Optimal Prices
Buying products on this site guarantees the best price
Flexible Batches
Flexible batch size to meet different needs of global customers
Prompt Delivery
Warehouses in multiple cities to ensure timely delivery
Quality Assurance
Strict process parameter control to ensure product quality
One-to-one Customization
One-to-one custom synthesis for special structural needs

Application Area

Environmental

Stable isotope-labeled compounds are used as environmental pollutant standards for the detection of air, water, soil, sediment and food.

Clinical diagnostic

In addition to treating various diseases, isotopes are used for imaging, diagnosis, and newborn screening.

Organic Chemistry

Small molecule compounds labeled with stable isotopes can be used as chemical reference for chemical identification, qualitative, quantitative, detection, etc. Various types of NMR solvents can be used to study the structure, reaction mechanism and reaction kinetics of compounds.

Metabolic Research

Stable isotope labeling allows researchers to study metabolic pathways in vivo in a safe manner.

Cefiderocol-[d6]

Inquiry

General Information
Catalog: BLP-001470
Molecular Formula: C30H28D6ClN7O10S2
Molecular Weight: 758.25

Chemical Structure

Description	Labelled Cefiderocol. This active molecular is a potent cephalosporin antibiotic with a catechol moiety on the 3-position side chain under the development of Shionogi. Cefiderocol exhibits potent activity against the non-fermenting Gram-negative bacteria in vitro including Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia. Now Cefiderocol is in clinical Phase III for treatment of severe infections caused by Carbapenem-resistant Gram-negative pathogens.
Related CAS	1225208-94-5 (unlabelled)
Purity	98%; 99% atom D